Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome

Journal of Gene Medicine

Volumn 11, Issue 8, 2009, Pages 645-654

  Mantovani, Julie ^a,b,c,f   Charrier, Sabine ^c,d   Eckenberg, Ralph ^e   Saurin, William ^e   Danos, Olivier ^a,b,c,g   Perea, Javier ^a,b,c   Galy, Anne ^c,d  

^a CNRS   (France)

^b UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^c GÉNÉTHON   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Genomining   (France)

^f MCGILL UNIVERSITY   (Canada)

^g INSERM   (France)

Author keywords

Genomic integration; Hematopoiesis; Lentiviral vector; Mouse; Wiskott Aldrich

Indexed keywords

GENOMIC DNA; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA INTEGRATION; EX VIVO STUDY; GENE INSERTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WISKOTT ALDRICH SYNDROME;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; MUS;

EID: 70349501369     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1346     Document Type: Article

References (17)

1. Charrier S, Stockholm D, Seye K, et al. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 2005; 12: 597-606.
2. Dupre L, Marangoni F, Scaramuzza S, et al. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/ cDNA-containing lentiviral vector and nonlethal irradiation. Hum Gene Ther 2006; 17: 303-313.
3. Charrier S, Dupre L, Scaramuzza S, et al. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients. Gene Ther 2007; 14: 415-428.
4. Marangoni F, Bosticardo M, Charrier S, et al. Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models. Mol Ther 2009; Mar 3 [Epub ahead of print].
5. Bushman F, Lewinski M, Ciuffi A, et al. Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 2005; 3: 848-858.
6. Mitchell RS, Beitzel BF, Schroder AR, et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004; 2: E234.
7. Kustikova OS, Geiger H, Li Z, et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark 'stemness' pathways. Blood 2007; 109: 1897-1907.
8. Beard BC, Dickerson D, Beebe K, et al. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther 2007; 15: 1356-1365.
9. Mantovani J, Holic N, Martinez K, Danos O, Perea J. A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Res 2006; 34: E134.
10. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998; 9: 81-91.
11. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
12. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 2006; 17: 253-263.
13. Sauvain MO, Dorr AP, Stevenson B, et al. Genotypic features of lentiviral transgenic mice. J Virol 2008; 82: 7111-7119.
14. Marshall HM, Ronen K, Berry C, et al. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS ONE 2007; 2: E1340.
15. Cattoglio C, Facchini G, Sartori D, et al. Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 2007; 110: 1770-1778.
16. Montini E, Cesana D, Schmidt M, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 2006; 24: 687-696.
17. Zanta-Boussif MA, Charrier S, Brice-Ouzet A, et al. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS. Gene Ther 2009; Mar 5 [Epub ahead of print].